Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...

The Novo Nordisk combo of liraglutide and insulin degludec in a single-injection delivery device is a good option for type 2 patients not controlled on oral agents and basal insulin, new data show.

Danish group Novo Nordisk's diabetes drug Victoza has a 43 percent chance of being approved as an obesity treatment in the United States, according to a Reuters poll which found Danish bank ...